A Study of PRCL-02 in Healthy Volunteers and Plaque Psoriasis
NCT03062618
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
50
Enrollment
OTHER
Sponsor class
Conditions
Psoriasis
Interventions
DRUG:
PRCL-02
DRUG:
Placebo Oral Tablet
Sponsor
PRCL Research Inc.